Holen Sie sich die Stockscreener-App
70.38
0.03%
0.02
Schlusskurs vom Vortag:
$70.36
Offen:
$70.24
24-Stunden-Volumen:
75,377
Relative Volume:
1.17
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.26%
1M Leistung:
+7.68%
6M Leistung:
+5.01%
1J Leistung:
+6.12%
1-Tages-Spanne:
$70.12
$71.09
1-Wochen-Bereich:
$68.66
$71.09
52-Wochen-Spanne:
$62.67
$72.94
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Firmenname
Ishares U S Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IHE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IHE
Ishares U S Pharmaceuticals Etf
|
70.38 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
300.69 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
606.32 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
609.40 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
250.24 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
529.60 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Aktie (IHE) Neueste Nachrichten
(IHE) Technical Pivots with Risk Controls - Stock Traders Daily
What Are Wall Street Analysts’ Target Price For Merck Stock? - Barchart
What Are Wall Street Analysts’ Target Price for Merck Stock? - Inkl
These ETFs can help investors protect themselves from selloffs like the DeepSeek panic — but here’s the catch - MarketWatch
iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Position Lessened by JPMorgan Chase & Co. - Defense World
How to Take Advantage of moves in (IHE) - Stock Traders Daily
Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery - Benzinga
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - MSN
ETFs Poised To Win Or Lose Under Trump's New Policies - Barchart
Barclays PLC Raises Stock Holdings in LifeVantage Co. (NASDAQ:LFVN) - Defense World
Treasury Metals (OTCMKTS:TSRMD) Stock Price Down 2.5% – Should You Sell? - Defense World
Franklin Resources Inc. Has $2.35 Million Holdings in Mach Natural Resources LP (NYSE:MNR) - Defense World
JPMorgan Chase & Co. Buys 75,592 Shares of First Trust Ultra Short Duration Municipal ETF (NYSEARCA:FUMB) - Defense World
Wealth Enhancement Advisory Services LLC Buys New Position in ALPS Disruptive Technologies ETF (NYSEARCA:DTEC) - Defense World
Wealth Enhancement Advisory Services LLC Has $299,000 Stock Position in Darling Ingredients Inc. (NYSE:DAR) - Defense World
Wealth Enhancement Advisory Services LLC Raises Stock Position in iShares U.S. Basic Materials ETF (NYSEARCA:IYM) - Defense World
Wealth Enhancement Advisory Services LLC Has $318,000 Stock Holdings in iShares MSCI China ETF (NASDAQ:MCHI) - Defense World
Wealth Enhancement Advisory Services LLC Acquires New Holdings in Invesco BulletShares 2027 Municipal Bond ETF (NASDAQ:BSMR) - Defense World
Wealth Enhancement Advisory Services LLC Raises Stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated at StockNews.com - Defense World
JPMorgan Chase & Co. Purchases 198,288 Shares of Columbia Diversified Fixed Income Allocation ETF (NYSEARCA:DIAL) - Defense World
JPMorgan Chase & Co. Sells 10,454 Shares of Invesco S&P 500 High Beta ETF (NYSEARCA:SPHB) - Defense World
Vanguard Short-Term Tax-Exempt Bond ETF (NYSEARCA:VTES) Holdings Raised by JPMorgan Chase & Co. - Defense World
JPMorgan Chase & Co. Has $4.38 Million Holdings in iShares U.S. Transportation ETF (BATS:IYT) - Defense World
JPMorgan Chase & Co. Sells 47,417 Shares of SPDR Portfolio Corporate Bond ETF (NYSEARCA:SPBO) - Defense World
JPMorgan Chase & Co. Sells 22,848 Shares of Vanguard Long-Term Bond ETF (NYSEARCA:BLV) - Defense World
100,000 Shares in JPMorgan Dividend Leaders ETF (NYSEARCA:JDIV) Acquired by JPMorgan Chase & Co. - Defense World
JPMorgan Chase & Co. Increases Position in International Money Express, Inc. (NASDAQ:IMXI) - Defense World
Canaccord Genuity Group Issues Pessimistic Forecast for Aspen Aerogels (NYSE:ASPN) Stock Price - Defense World
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - MSN
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - MSN
Long Term Trading Analysis for (IHE) - Stock Traders Daily
Eli Lilly Cuts Q4 Sales Forecast: ETFs To Buy On The Dip - Barchart
Eli Lilly Lowers Q4 Sales Outlook: Best ETFs to Consider Now - espeaks.co.uk
6 Best Health Care ETFs to Buy for 2025 | Investing - U.S News & World Report Money
Objective long/short (IHE) Report - Stock Traders Daily
John Marshall Bancorp, Inc. (NASDAQ:JMSB) Shares Purchased by Barclays PLC - Defense World
LAVA Therapeutics NV Files 8-K with SEC, Transitioning to U.S. Domestic Issuer Status - Defense World
iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Bought by Jane Street Group LLC - Defense World
Jane Street Group LLC Cuts Stock Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World
Top U.S. health care mid-cap stocks and their Quant Ratings (NYSEARCA:IYH) - Seeking Alpha
How the (IHE) price action is used to our Advantage - Stock Traders Daily
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - MSN
iShares Emerging Markets Infrastructure ETF declares semi-annual distribution of $0.4838 - MSN
J.P. Morgan’s top Healthcare stocks for 2025 (NYSEARCA:XLV) - Seeking Alpha
Fmr LLC Acquires 1,338 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
Fmr LLC Has $1.21 Million Stock Position in iShares MSCI Europe Financials ETF (NASDAQ:EUFN) - Defense World
IHF: Healthcare Dashboard For December (NYSEARCA:IHF) - Seeking Alpha
Analyzing United States Antimony (NYSE:UAMY) and Stardust Power (NASDAQ:SDST) - Defense World
Trend Tracker for (IHE) - Stock Traders Daily
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares - Benzinga
Finanzdaten der Ishares U S Pharmaceuticals Etf-Aktie (IHE)
Es liegen keine Finanzdaten für Ishares U S Pharmaceuticals Etf (IHE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):